PriceTargets.com logo

Futura Medical - FUM Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 32.05 As of 12/27/2024 12:46 PM ET
▲ +0.35 (1.10%)

This chart shows the closing price for FUM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Futura Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for FUM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for FUM

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Futura Medical in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 32.05.

This chart shows the closing price for FUM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Futura Medical. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/7/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/5/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/2/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/29/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/28/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/28/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/31/2021Libertas PartnersReiterated RatingBuyGBX 102
6/3/2021Liberum CapitalBoost TargetBuyGBX 80 ➝ GBX 102
4/14/2021Liberum CapitalReiterated RatingBuyGBX 68
7/14/2020Liberum CapitalReiterated RatingBuy
6/24/2020Liberum CapitalReiterated RatingBuy
5/18/2020Liberum CapitalReiterated RatingBuyGBX 55
4/20/2020Liberum CapitalReiterated RatingUnder Review
4/1/2020Liberum CapitalReiterated RatingUnder Review
3/18/2020Liberum CapitalReiterated RatingUnder Review
2/13/2020Liberum CapitalReiterated RatingUnder Review
(Data available from 12/28/2019 forward)

News Sentiment Rating

0.94 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/1/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/1/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/31/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/30/2024
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/29/2024
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/29/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/28/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/28/2024

Current Sentiment

  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Futura Medical logo
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Read More

Today's Range

Now: GBX 32.05
Low: 31.41
High: 32.15

50 Day Range

MA: GBX 34.37
Low: 31.40
High: 38.95

52 Week Range

Now: GBX 32.05
Low: 21.50
High: 47.80

Volume

52,909 shs

Average Volume

633,646 shs

Market Capitalization

£96.92 million

P/E Ratio

N/A

Dividend Yield

4.55%

Beta

1.25

Frequently Asked Questions

What sell-side analysts currently cover shares of Futura Medical?

The following sell-side analysts have issued reports on Futura Medical in the last year:
View the latest analyst ratings for FUM.

What is the current price target for Futura Medical?

0 Wall Street analysts have set twelve-month price targets for Futura Medical in the last year. has the lowest price target set, forecasting a price of £100,000 for Futura Medical in the next year.
View the latest price targets for FUM.

What is the current consensus analyst rating for Futura Medical?

Futura Medical currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for FUM.

What other companies compete with Futura Medical?

Other companies that are similar to Futura Medical include PureTech Health, Horizon Discovery Group plc (HZD.L), Verona Pharma plc (VRP.L), Arix Bioscience and Faron Pharmaceuticals Oy. Learn More about companies similar to Futura Medical.

How do I contact Futura Medical's investor relations team?

Futura Medical's physical mailing address is 40 Surrey Technology Centre, Occam Road, GUILDFORD, GU2 7YG, United Kingdom. The company's listed phone number is +44-1483-685670. The official website for Futura Medical is www.futuramedical.com. Learn More about contacing Futura Medical investor relations.